Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: single brain metastasisJohn H Suh, Gregory M M Videtic, Amr M Aref, et al.International Journal of Radiation Oncology, Biology, Physics|December 2, 2019
High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539C Leland Rogers, Minhee Won, Michael A Vogelbaum, et al.Neuro-Oncology|November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS LymphomaAntonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.Neuro-Oncology|June 3, 2022
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, et al.International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk MeningiomaRupesh Kotecha, Mei-Yin Polley, Michael A Vogelbaum, et al.Neuro-Oncology|January 14, 2025
Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial DesignRupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, et al.Neuro-Oncology|May 17, 2026
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant MeningiomasLeeor S Yefet, Alexander P Landry, C Leland Rogers, et al.Nature Medicine|August 21, 2024
Molecular classification to refine surgical and radiotherapeutic decision-making in meningiomaJustin Z Wang, Vikas Patil, Alexander P Landry, et al.Pageof 5